Navigation Links
Aspirin at Bedtime Lowers Blood Pressure
Date:5/14/2008

No benefit seen for prehypertensive people in morning use, researchers report

WEDNESDAY, May 14 (HealthDay News) -- A daily aspirin can control prehypertension, but only if it is taken at bedtime, a Spanish study shows.

An aspirin taken every morning didn't lower the blood pressure of prehypertensive people, but the evening regimen did, Dr. Ramon C. Hermida reported Wednesday at the American Society of Hypertension annual meeting, in New Orleans.

A previous study by Hermida, who is director of bioengineering and chronobiology at the University of Vigo, showed the same beneficial effect of bedtime aspirin for people with moderately high blood pressure. The new report is the first study to show the drug's benefit -- although only when taken at night -- with prehypertension, defined as blood pressure just below the 140/90 level. Prehypertension is a known warning sign of future risk of heart disease, stroke and other cardiovascular problems.

Why aspirin should do its good work for blood pressure at night but not in the daytime is not clear, Hermida said. Research indicates that it can slow the production of hormones and other substances in the body that cause clotting, many of which are produced while the body is at rest.

The three-month study included 244 adults diagnosed with prehypertension. A third of them were advised to follow general rules of hygiene and diet designed to reduce blood pressure, another third were told to take a 100-milligram aspirin tablet every night at bedtime, and the final third were told to take the same aspirin dose on awakening.

Researchers monitored blood pressure levels at 20-minute intervals from 7 a.m. to 11 p.m. and at 30-minute intervals at night before the trial began and three months later.

Systolic blood pressure (the higher number in the 140/90 reading) dropped 5.4 points and diastolic pressure by 3.4 points for those taking aspirin before bedtime. No drop in blood pressure was found in those taking morning aspirin or following the general guidelines.

"There is some evidence that taking a variety of medications, including those for hypertension, at night is associated with greater blood pressure reduction than taking them in the morning," said Dr. Suzanne Oparil, president of the American Society for Hypertension. "I don't think we know why."

It's possible that there might be better absorption of the medication by the gastrointestinal tract at night, said Oparil, who is a professor of medicine at the University of Alabama at Birmingham.

"It's all a little bit speculative about why, but I think the observation is solid," she said.

In a statement, Hermida said the new findings "show us that we cannot underestimate the impact of the body's circadian rhythms."

"The beneficial effects of time-dependent administration of aspirin have until now been largely unknown in people with prehypertension," he said. "Personalizing treatment according to one's own rhythms gives us a new option to optimize blood pressure control and reduce the risk of cardiovascular disease down the line."

More information

Aspirin in all its aspects is described by the U.S. National Library of Medicine.



SOURCES: Suzanne Oparil, M.D., professor, medicine, University of Alabama at Birmingham; May 14, 2008, presentation, American Society of Hypertension annual meeting, New Orleans


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
2. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
3. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
4. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
5. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
6. Aspirin Resistance Boosts Heart Risks in Cardiac Patients
7. Regular, long-term aspirin use reduces risk of colorectal cancer
8. Many stroke, heart attack patients may not benefit from aspirin
9. Women are treated less frequently than men with statins, aspirin and beta-blockers
10. Drugs like aspirin could reduce breast cancer and help existing sufferers
11. Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting in Denver
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin at Bedtime Lowers Blood Pressure
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management ... radiology marketing programs at the annual Building Better Radiology Marketing Programs conference, ... Hotel in Fort Worth, Texas. Nine awards are given out in five categories. They ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: